“alnylam-pharmaceuticals” Archives

in
Entry Author Date Location
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue 04/11/16 Boston
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Arrowhead’s Novartis RNAi Deal: Big Boost or ‘Stale Potato Chips’? 03/09/15 Wisconsin
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
WaVe Gets $18M to Solve RNA’s “Underappreciated” Chemistry Problem 02/02/15 Boston
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
Page 1 of 10 next page »